Livzon Pharmaceutical Group Inc Free Cash Flow Generation Index
Livzon Pharmaceutical Group Inc free cash flow generation index. Livzon Pharmaceutical Group Inc (000513) has a Free Cash Flow Generation Index of 0.87x as of December 2025. Free cash flow of CN¥546.97 Million represents 1% of operating cash flow (CN¥625.70 Million). Check 000513 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Livzon Pharmaceutical Group Inc (1999–2025)
Free cash flow generation index of Livzon Pharmaceutical Group Inc from 1999 to 2025. Historical FCF Generation Index trend for Livzon Pharmaceutical Group Inc across 27 annual periods. Explore Livzon Pharmaceutical Group Inc (000513) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Livzon Pharmaceutical Group Inc Free Cash Flow Generation Index by Year (1999–2025)
Livzon Pharmaceutical Group Inc free cash flow generation index by year from 1999 to 2025. Year-by-year Free Cash Flow Generation Index for Livzon Pharmaceutical Group Inc. For the full cash flow conversion analysis, see Livzon Pharmaceutical Group Inc cash conversion from operations.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥2.60 Billion | CN¥3.18 Billion | CN¥574.14 Million | ▲ +1.3% |
| 2024 | 0.81x | CN¥2.41 Billion | CN¥2.98 Billion | CN¥570.16 Million | ▲ +8.2% |
| 2023 | 0.75x | CN¥2.43 Billion | CN¥3.25 Billion | CN¥820.45 Million | ▲ +13.1% |
| 2022 | 0.66x | CN¥1.83 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▲ +111.9% |
| 2021 | 0.31x | CN¥593.23 Million | CN¥1.90 Billion | CN¥1.31 Billion | ▼ -55.5% |
| 2020 | 0.70x | CN¥1.51 Billion | CN¥2.16 Billion | CN¥646.98 Million | ▼ -9.6% |
| 2019 | 0.77x | CN¥1.37 Billion | CN¥1.77 Billion | CN¥398.00 Million | ▲ +23.8% |
| 2018 | 0.63x | CN¥793.15 Million | CN¥1.27 Billion | CN¥474.47 Million | ▼ -19.4% |
| 2017 | 0.78x | CN¥1.02 Billion | CN¥1.32 Billion | CN¥294.15 Million | ▲ +9.1% |
| 2016 | 0.71x | CN¥910.76 Million | CN¥1.28 Billion | CN¥368.46 Million | ▲ +46.6% |
| 2015 | 0.49x | CN¥450.65 Million | CN¥927.79 Million | CN¥477.13 Million | ▲ +571.7% |
| 2014 | 0.07x | CN¥51.87 Million | CN¥717.39 Million | CN¥665.52 Million | ▲ +106.6% |
| 2013 | -1.09x | CN¥-480.01 Million | CN¥439.99 Million | CN¥920.00 Million | ▼ -284.9% |
| 2012 | -0.28x | CN¥-168.34 Million | CN¥593.96 Million | CN¥762.30 Million | ▼ -155.9% |
| 2011 | 0.51x | CN¥359.37 Million | CN¥708.20 Million | CN¥348.83 Million | ▲ +8.4% |
| 2010 | 0.47x | CN¥296.34 Million | CN¥633.30 Million | CN¥336.95 Million | ▼ -36.3% |
| 2009 | 0.73x | CN¥363.47 Million | CN¥494.88 Million | CN¥131.41 Million | ▼ -6.0% |
| 2008 | 0.78x | CN¥269.66 Million | CN¥345.18 Million | CN¥75.52 Million | ▲ +23.5% |
| 2007 | 0.63x | CN¥157.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▲ +211.4% |
| 2006 | 0.20x | CN¥46.01 Million | CN¥226.46 Million | CN¥180.45 Million | ▲ +134.2% |
| 2005 | -0.59x | CN¥-95.65 Million | CN¥161.07 Million | CN¥256.72 Million | ▼ -408.0% |
| 2004 | 0.19x | CN¥34.98 Million | CN¥181.46 Million | CN¥146.48 Million | ▼ -70.6% |
| 2003 | 0.65x | CN¥196.45 Million | CN¥300.01 Million | CN¥103.56 Million | ▲ +27.1% |
| 2002 | 0.52x | CN¥110.03 Million | CN¥213.65 Million | CN¥103.62 Million | ▲ +8.5% |
| 2001 | 0.47x | CN¥73.66 Million | CN¥155.15 Million | CN¥81.48 Million | ▲ +179.6% |
| 2000 | -0.60x | CN¥-22.98 Million | CN¥38.52 Million | CN¥61.49 Million | ▼ -185.0% |
| 1999 | 0.70x | CN¥172.78 Million | CN¥246.23 Million | CN¥73.44 Million | — |